Caring for children with cancer
We explore the world of award-winning cancer scientist, Dr Sam Behjati
Read more
Author: Communications Team
Sanger’s super-sized sequencing scales new heights
We’re celebrating: we’ve just read the same amount of DNA in one year as we achieved in the previous 25 years combined. This dizzying speed offers unprecedented possibilities to unlock new understanding in health and disease
Read more
CRAM-ming it in
An impending flood of genomic data threatens to overwhelm scientists’ abilities to store and share it. Next-generation compression seeks to CRAM it all in
Read more
The importance of public engagement on antibiotic resistance
Nicole Wheeler talks antibiotics, antibiotic resistance and public engagement – and letting people use real software on real data to track antibiotic resistance around the world
Read more
Disability, Inclusion and Science
Distinguished disability rights campaigner, David Ruebain, joined us last month at the Wellcome Genome Campus. He spoke on disability and inclusion in science, as part of the campus Equality in Science event series.
Read more
Human genome editing – the issues explored
Hayley Clissold from the Sanger Institute’s policy team team explores the issues surrounding gene editing and human embryos
Read more
Hasta la VISA, genomes!
From ragworts that are too common and the tricky toughness of truffles to the trials of getting DNA samples a US Visa, Dan Mead gives his personal reflections on project managing the 25 Genomes Project
Read more
Chernobyl: chasing a ‘catching’ cancer
Sanger researcher Alex Cagan travelled to Chernobyl’s nuclear exclusion zone for samples of cancer. But he isn’t investigating the effects of the reactor disaster; his quarry has a more ancient source: the immortal cells of an 8,000 year-old animal that are still being passed from dog to dog
Read more
Human Embryo Editing: science fiction or science fact?
Anna Middleton, Head of the Society and Ethics research group at Wellcome Genome Campus Connecting Science, reports on Prof He Jiankiu’s unverified announcement of gene editing the first human embryos that have been born
Read more
Dr Cordelia Langford wins BioBeat award
The ‘50 Movers and Shakers in BioBusiness 2018’ report identifies outstanding women who are developing revolutionary bioscience. Dr Cordelia Langford, Director of Scientific Operations at the Wellcome Sanger Institute is celebrated in the collaboration category. Ahead of the BioBeat 2018 conference, we spoke to Cordelia about her career and her role as a leading woman in science
Read more